Rapid Test
Lateral flow rapid tests, also known as point-of-care (POC) tests or near-patient tests, are diagnostic tests that are performed at the point of care, such as in a physician's office or clinic.
They are widely used across many industries due to their ease of use and the ability to provide quick results, often within minutes, which can be useful in making clinical decisions.
Lateral flow immunoassay (LFIA) technology has been around since the 1980s, when the first lateral flow test was developed for pregnancy detection. Since then, LFIA technology has been widely used for various applications, including COVID-19 testing and drug testing.
Lateral Flow Rapid Tests
Lateral flow rapid tests, also known as point-of-care (POC) tests or near-patient tests, are diagnostic tests that are performed at the point of care, such as in a physician’s office or clinic.
They are widely used across many industries due to their ease of use and the ability to provide quick results, often within minutes, which can be useful in making clinical decisions.
Lateral flow immunoassay (LFIA) technology has been around since the 1980s, when the first lateral flow test was developed for pregnancy detection. Since then, LFIA technology has been widely used for various applications, including COVID-19 testing and drug testing.
Why Consider This Test?
Lateral flow immunoassay (LFIA) technology has numerous clinical applications in medical diagnosis, screening, and monitoring.
Infectious disease testing
Cardiac biomarker testing
Cancer biomarker testing
Hormone testing
Why Consider This Test?
Lateral flow immunoassay (LFIA) technology has numerous clinical applications in medical diagnosis, screening, and monitoring.
such as HIV, hepatitis B and C, syphilis, chlamydia, gonorrhea, malaria, and COVID-19. LFIA test kits for COVID-19 have been particularly useful for rapid screening and surveillance.
Infectious
Disease Testing
such as troponin, myoglobin, and creatine kinase, which can indicate heart damage or disease.
Cardiac Biomarker Testing
such as prostate-specific antigen (PSA), alpha-fetoprotein (AFP), and carcinoembryonic antigen (CEA), which can help diagnose and monitor various types of cancer.
Cancer
Biomarker Testing
Such as human chorionic gonadotropin (hCG), luteinizing hormone (LH), Follicle Stimulating Hormone (FSH)
Hormone
Testing
How We Can Help
Through years of experience in the diagnostics industry, we have gathered and established a strong network of industry experts and companies that specialize in the development and manufacturing of lateral flow rapid test devices. With both domestic and international manufacturing partners, we ensure stable, agile, and scalable manufacturing supply chain.
